Bladder Cancer

FEATURES

Cytology and Biomarkers in NMIBC

Cystoscopy and cytology remain the standard for diagnosis, but a plethora of urinary biomarkers could someday be a useful adjunct to NMIBC surveillance.

Latest Bladder Cancer News

Robotic-Assisted Radical Cystectomy Safe, Feasible for Octogenarians

October 8, 2021

The benefits of robotic surgery may have a more pronounced effect in octogenarians, according to investigators.

Neoadjuvant Chemo May Improve Outcomes for MIBC of Variant Histology

September 30, 2021

Findings refute the notion that variant histology MIBC will not respond to neoadjuvant chemotherapy.

Multiple patients having chemotherapy in a room

dd-MVAC Regimen ‘Should Be Gold Standard’ for Muscle-Invasive Bladder Cancer

September 17, 2021

Dose-dense methotrexate plus vinblastine, doxorubicin, and cisplatin improved time to progression.

Blood-Based Test May Establish a ‘New Paradigm’ for Cancer Screening

September 15, 2021

The test can accurately detect cancer and predict where it is located, according to researchers.

CKD Associated With Worse Radical Cystectomy Outcomes

September 13, 2021

Investigators report increased risks for adverse pathology and 90-day readmission.

Partial, Radical Cystectomy for MIBC Yield Similar Survival Outcomes

September 13, 2021

In addition to similar rates of overall survival, patients undergoing partial and radical cystectomy had comparable rates of upstaging to pT3-4 disease.

BCG for Bladder Cancer May Lower Alzheimer Disease Risk

September 13, 2021

The risk for alzheimer disease decreased with increased dosing of BCG.

Primary Chemoablation for Low-Grade Intermediate-Risk NMIBC Promising

September 12, 2021

A mitomycin-containing reverse thermal gel could provide an alternative to repetitive surgeries for low-grade intermediate-risk NMIBC, according to investigators.